Results 21 to 30 of about 16,330 (302)

Harnessing Deep Convolutional Neural Networks Detecting Synthetic Cannabinoids: A Hybrid Learning Strategy for Handling Class Imbalances in Limited Datasets

open access: yesInventions, 2023
The aim of this research was to develop and deploy efficient deep convolutional neural network (DCNN) frameworks for detecting and discriminating between various categories of designer drugs. These are of particular relevance in forensic contexts, aiding
Catalina Mercedes Burlacu   +3 more
doaj   +1 more source

Sequence-based drug design as a concept in computational drug design

open access: yesNature Communications, 2023
AbstractDrug development based on target proteins has been a successful approach in recent decades. However, the conventional structure-based drug design (SBDD) pipeline is a complex, human-engineered process with multiple independently optimized steps.
Lifan Chen   +23 more
openaire   +3 more sources

Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs

open access: yesCombinatorial Chemistry & High Throughput Screening, 2015
Due to the time and effort requirements for the development of a new drug, and the high attrition rates associated with this developmental process, there is an intense effort by academic and industrial researchers to find novel ways for more effective drug development schemes.
Kellici T   +13 more
openaire   +4 more sources

Pharmacology of amphetamine-type designer drugs [PDF]

open access: yes, 2013
In this thesis project, we studied the pharmacology of long-known psychostimulants and of novel amphetamine-type designer drugs in vitro. On the basis of the pharmacological characterization, we focused on the drug effects in humans, investigating the ...
Simmler, Linda
core   +1 more source

Uzasadnienie i propozycja projektu przepisów karnych mających na celu zwalczanie obrotu tak zwanymi dopalaczami przez jednostki samorządu terytorialnego

open access: yesActa Iuris Stetinensis, 2018
In view of the very serious social problem of designer drugs, which is growing with every passing day, we must take resolute and effective action as quickly as possible.
Piotr Jóźwiak
doaj   +1 more source

Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine. [PDF]

open access: yesFarmacja Polska, 2020
Research on using drugs in medicine was almost completely stopped and delegalized in 1971, by Convention on Psychotropic Substances. Most of studies carried out before 1971 were methodologically inappropriate according to current research methodologies ...
Agata Tadeja
doaj   +1 more source

Targeted Delivery of Chemogenetic Adeno-Associated Viral Vectors to Cortical Sulcus Regions in Macaque Monkeys by Handheld Injections

open access: yesBio-Protocol, 2023
Recent advancements in chemogenetic tools, such as designer receptors exclusively activated by designer drugs (DREADDs), allow the simultaneous manipulation of activity over a specific, broad brain region in nonhuman primates.
Kei Oyama   +2 more
doaj   +1 more source

Between designer drugs and afterburners: A Lexicographic-Semantic Study of Equivalence

open access: yesLexikos, 2021
The lexicons of natural languages are not isomorphic. Reasons for the anisomorphism can be sought on three interrelated planes: language structure, extralinguistic reality, and conceptualisation.
Arleta Adamska-Sałaciak
doaj   +1 more source

Identificação química da clorofenilpiperazina (CPP) em comprimidos apreendidos Chemical identification of chlorophenylpiperazine in seized tablets

open access: yesQuímica Nova, 2010
Designer drug is a term used to describe psychoactive drugs of abuse which are usually synthesized by modifying the molecular structures of existing drugs of abuse.
Rafael Lanaro   +3 more
doaj   +1 more source

Artykuł 160 k.k. jako (potencjalny) środek walki z niektórymi spośród społecznie niepożądanych zachowań związanych z dopalaczami

open access: yesActa Iuris Stetinensis, 2018
The goal of this work is to answer a question if the regulations of art. 160 § 1–3 k.k. could be used in combating designer drugs. The findings of this work are based on: 1) analysis of the normative materials referring to the examined issue; and – 2 ...
Konrad Burdziak
doaj   +1 more source

Home - About - Disclaimer - Privacy